Prevalence and risk factors of transmission of hepatitis delta virus in pregnant women in the Center Region of Cameroon
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0287491 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Juliette-Laure Ndzie Ondigui und 16 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Sciences, Department of Microbiology, University of Yaoundé 1, Yaounde, Cameroon. Hauptthemen laut MEDLINE: Hepatitis D, Hepatitis Delta Virus, Pregnancy Complications, Infectious, Infectious Disease Transmission, Vertical. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIRCB, Sasakawa Memorial Health Foundation.
Abstract (Originalsprache)
Background
Hepatitis B virus (HBV) and hepatitis delta virus (HDV) co-infection has been described as the most severe form of viral hepatitis, and can be co-transmitted from mother-to-child. A seroprevalence of 4.0% of HDV infection was reported in pregnant women in Yaoundé, and 11.9% in the general population in Cameroon. Our objective was to describe the rate of HDV infection in HBsAg-positive pregnant women and to determine risk factors associated with mother-to-child transmission of HDV. Materials and methods A cross-sectional, descriptive study was conducted from January 2019 to July 2022 among pregnant women attending antenatal contacts in seven health structures in the Centre Region of Cameroon. A consecutive sampling (non-probability sampling) was used to select only pregnant women of age over 21 years, who gave a written informed consent. Following an informed consent, an open-ended questionnaire was used for a Knowledge, Attitude and Practice (KAP) survey of these women, and their blood specimens collected and screened for HBsAg, anti-HIV and anti-HCV antibodies by rapid tests and ELISA. HBsAg-positive samples were further screened for HBeAg, anti-HDV, anti-HBs, and anti HBc antibodies by ELISA, and plasma HDV RNA load measured by RT-qPCR.
Results
Of 1992 pregnant women, a rate of 6.7% of HBsAg (133/1992) with highest rate in the rural areas, and 3.9% of hepatitis vaccination rate were recorded. Of 130, 42 (32.3%) were anti-HDV antibody-positive, and 47.6% had detectable HDV RNA viraemia. Of 44 anti-HDV-positive cases, 2 (4.5%) were co-infected with HBV and HCV, while 5 (11.4%) with HIV and HBV. Multiple pregnancies, the presence of tattoos and/or scarifications were significantly associated with the presence of anti-HDV antibodies. Of note, 80% of women with negative HBeAg and positive anti-HBe serological profile, had plasma HDV RNA load of more than log 3.25 (>10.000 copies/ml).
Conclusion
These results show an intermediate rate of HDV infection among pregnant women with high level of HDV RNA viremia, which suggest an increased risk of vertical and horizontal co-transmission of HDV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Sciences, Department of Microbiology, University of Yaoundé 1, Yaounde, Cameroon.
- Chantal BIYA" International Reference Center for Research on HIV/AIDS Prevention and Management (CIRCB), Yaounde, Cameroon.
- Department of Food Science and Nutrition, National School of Agro-Industrial Sciences, University of Ngaoundere, Ngaoundere, Cameroon.
- Yaoundé Gyanecology Obstetrics and Paediatrics Hospital, Yaounde, Cameroon.
- Faculty of Medicine and Biomedical Sciences, Department of Biochemistry, University of Yaounde 1, Yaounde, Cameroon.
- Faculty of Medicine and Biomedical Sciences, Department of Public Health, University of Yaounde 1, Yaounde, Cameroon.
ORCID-Profile: Judith Torimiro
Förderung
- CIRCB
- Sasakawa Memorial Health Foundation
Zitieren
APA
Ndzie Ondigui, J. L., Mafopa Goumkwa, N., Lobe, C., Wandji, B., Awoumou, P., Voussou Djivida, P., Peyonga, P., Manju Atah, S., Verbe, V., Kamgaing Simo, R., Moudourou, S. A., Gutierrez, A., Garcia, R., Fernandez, I., Riwom Essama, S. H., Mbu, R., & Torimiro, J. (2024). Prevalence and risk factors of transmission of hepatitis delta virus in pregnant women in the Center Region of Cameroon. PLOS ONE. https://doi.org/10.1371/journal.pone.0287491
Vancouver
Ndzie Ondigui JL, Mafopa Goumkwa N, Lobe C, Wandji B, Awoumou P, Voussou Djivida P, et al. Prevalence and risk factors of transmission of hepatitis delta virus in pregnant women in the Center Region of Cameroon. PLOS ONE. 2024. doi:10.1371/journal.pone.0287491
BibTeX
@article{NdzieOndigui2024,
author = {Ndzie Ondigui, Juliette-Laure and Mafopa Goumkwa, Nadège and Lobe, Cindy and Wandji, Brigitte and Awoumou, Patrick and Voussou Djivida, Prisca and Peyonga, Puinta and Manju Atah, Solange and Verbe, Vivian and Kamgaing Simo, Rachel and Moudourou, Sylvie Agnès and Gutierrez, Ana and Garcia, Rosi and Fernandez, Isabelle and Riwom Essama, Sara Honorine and Mbu, Robinson and Torimiro, Judith},
title = {Prevalence and risk factors of transmission of hepatitis delta virus in pregnant women in the Center Region of Cameroon},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0287491}
}
EUVIMED